
    
      The purpose of this study is to assess the abuse potential of CL-108 tablets, including the
      abuse deterrent effects of promethazine, following oral administration, relative to
      hydrocodone/acetaminophen (APAP) tablets and placebo in non-dependent, recreational opioid
      users; to assess the cognitive and behavioral effects of CL-108 tablets following oral
      administration relative to hydrocodone/APAP tablets and placebo in non-dependent,
      recreational opioid users; and to assess the safety of orally administered CL-108 tablets
      relative to hydrocodone/APAP tablets and placebo in non-dependent, recreational opioid users.
    
  